Diabetes drug showdown: which works better for indian patients?
NCT ID NCT07311551
Summary
This study compares two common diabetes medications, dapagliflozin and empagliflozin, to see which works better for Indian patients with type 2 diabetes and higher body weight. Researchers will measure blood sugar control, weight changes, organ function, and treatment costs over six months. The results will help doctors choose the most effective and affordable option for their patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.